Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-30

Clinical Trial Update: Efficacy and Safety of Chinese Herbal HuoXue LiShui Formula for Chronic Subdural Hematoma [NA]

View source ↗

Summary

Clinical trial update on the efficacy and safety of the Chinese herbal HuoXue LiShui Formula for chronic subdural hematoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HuoXue LiShui Formula

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Chronic Subdural Hematoma | NA | Status: NOT_YET_RECRUITING